page_banner

Products

N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N. CAS: 211914-50-0

Description:

Catalogue Number: XD93358
Cas: 211914-50-0
Formulae hypotheticae: C27H30ClN7O3
Pondus hypotheticum: 536.03
Availability: In Stock
Pretium:  
Prepack:  
Mole Pack: Request Quote

 


Product Detail

Product Tags

Catalogue Number XD93358
Product Name N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N.
CAS 211914-50-0
Formulae hypotheticaela C27H30ClN7O3
M. Pondus 536.03
Repono Details Ambiens

 

Product Specification

Aspectus Pulvis albus
Assay 99% min

 

N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride vulgo ad ut compositum, est ens chemicum cum structura et nomine complexa.Haec compositio varias applicationes potentiales in variis campis habet, notissime in chemiae medicinali et medicamento progressu. In agro chemiae medicinalis, haec compositio pollicetur ut potentia pharmacum candidatum vel pharmaceuticum medium.Eius structura chemica varias coetus functiones incorporat, quae actionem biologicam modulare possunt, scopo ambiente ad ulteriorem explorationem faciendo.Anulus benzimidazolus intra suam structuram variis actionibus biologicis sociatus est et in compositis pharmaceuticis communiter invenitur.Consequenter investigatores suos effectus therapeuticos potentiales investigare potuerunt, ut antimicrobiales, anticancer, vel anti-inflammatorias proprietates. Unicum compositum structura etiam fores synthesis organicae aperit.Chemici organici suas functiones uti possunt ad varias chemicae transformationes perficiendas, creationem moleculorum multipliciorum cum proprietatibus formandis permittens.Praeclaram structuram obstruere potest ad compositiones ad applicationes in diversis locis designandas et componendas, inter materias scientias et investigationes speciales agrorum. Attamen interest animadvertere exactam usum et efficaciam huius compositi accuratam inquisitionem et aestimationem requirere.Studia essentialia, etiam aestimationes pharmacokineticas, analysis toxicitas et pertentationes biologicae comprehensivae, necessariae sunt determinare eius potentiam ut medium medicamentum vel pharmaceuticum.Investigatores inquirere debent suas interactiones cum scutis biologicis, bioavailability et potentiali adversis effectibus, ut eius viability applicationes medicinales recte perpendant. Cum laborantibus N-[[2-[[4-(Aminoiminomethyl)phenyl]amino]methyl]- 1-methyl-1H-benzimidazol-5-yl] carbonylum]-N-(2-pyridinyl) hydrochloridum ethyl-beta-alaninum ester, cautela recte adhibenda est.Haec includit strictam tractationem et rationes repositionis adhaerens, quae operam dare possunt in area bene ventilata et aptis instrumentis tutelae.Salutis notitia schedae et normae a praebitoribus instructae consulendae sunt et sequendae ad mitiganda discrimina potential cum hac compositione coniungenda. In summa, N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl- 1H-benzimidazol-5-yl] carbonyl]-N-(2-pyridinyl)-beta-alaninum ethyl niensis hydrochloride demonstrat potential applicationes in chemia medicinali et organica synthesi.Sed ulterius investigatio et experimenta necessaria sunt ad plene explorandum eius potentialem therapeuticam, eiusque agendi machinas comprehendere, eius salutem et efficaciam aestimare.


  • Priora:
  • Deinde:

  • Close

    N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N. CAS: 211914-50-0